Genomictree

South Korea · Founded 2000 · $51.5M raised

Founded
2000
Business Model
B2B
Total Funding
$51.5M
Last Round
$4.0M Venture RoundAug 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genomictree develops non-invasive molecular diagnostics for early cancer detection and multiplex detection of infectious diseases. The company identifies DNA methylation biomarker candidates through a genomic-scale discovery tool and develops methylation biomarkers using sensitive methylation-detection technology. Its proprietary Allele Specific Reactive Primer (ASRP)-mediated PCR and Linear Target Enrichment (LTE) platforms enable liquid-biopsy tests from bodily fluids and multiplex PCR assays that identify multiple human pathogens in clinical specimens. Genomictree commercializes products such as EarlyTect Colon Cancer and aims to enter the global market as a leading company in early cancer diagnosis.

Summary

Genomictree is a Biotech company based in South Korea, founded in 2000. It has raised $51.5M in total across 2 rounds, most recently a $4.0M Venture Round in Aug 2021. Investors include Orion Capital Asia, KB Investment and Mirae Asset Venture Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2021
$4.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genomictree on Indexed.vc
<a href="https://indexed.vc/companies/genomictree"><img src="https://indexed.vc/api/badge/company/genomictree" alt="Genomictree on Indexed.vc" width="260" height="76" /></a>